Platinum-based antitumor drugs have been used in many types of tumors due to its broad
antitumor spectrum in clinic. Encouraged by the cisplatin's (CDDP) worldwide success in …

Platinum drugs with manifest therapeutic effects are widely used, but their systemic toxicity
and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the …

Triple-negative breast cancer (TNBC) is one major type of cancer for which there has been
no effective therapy to date. An important reason for it being the lack of expression of …

Nanomedicines are highly promising for cancer therapy due to their minimal side effects.
However, little is known regarding their host immune response, which may limit their clinical …

Lung cancer is one of the leading causes of death in both males and females, and it is the
first causes of cancer-related deaths. Chemotherapy, surgery and radiotherapy are …

Hyaluronic acid (HA) is a naturally occurring polysaccharide which has been extensively
exploited in biomedical fields owing to its outstanding biocompatibility. Self‐assembly of HA …

Hyaluronic acid (HA) represents a natural polysaccharide which has attracted significant
attention owing to its improved tumor targeting capacity, enzyme degradation capacity, and …

Lung cancer (LC) is one of the leading causes of cancer occurrence and mortality
worldwide. Treatment of patients with advanced and metastatic LC presents a significant …

Platinum-based anticancer drugs can inhibit the growth of cancer cells by disrupting DNA
replication, which makes them widely applicable in clinics for treating tumors and cancers …

On a global scale, lung cancer is acknowledged to be the major driver of cancer death
attributable to treatment challenges and poor prognosis. Classical cancer treatment …